E-DRUG: Patent Pool session at the 62nd WHA
-------------------------------------------
HIV/AIDS Medicines Patent Pool
UNITAID Briefing for Delegates to the 62nd World Health Assembly
Wednesday 20th May 2009, 18h -20h
Palais des Nations, Geneva - Room VIII
Moderator: Charles Clift, Senior Adviser Access to Medicines, Department for International Development (UK)
Welcome and opening
Dr Philippe Douste-Blazy, Chair of UNITAID Board and UN Under-Secretary-General, Special Adviser on Innovative Financing for Development
Panel
Update on the UNITAID Patent Pool initiative
Ellen 't Hoen, Senior Adviser IP and Medicines Patent Pool, UNITAID
Patent Pool and the missing HIV/AIDS medicines
Dr Alexandra Calmy, Cheffe de clinique scientifique, Service de Maladies Infectieuses, Unité VIH/SIDA, Hôpitaux Universitaires de Genève and HIV adviser Médecins sans Frontières Access Campaign
A country perspective
Dr. Albert Mwango, ARV Programme Coordinator, Ministry of Health, Republic of Zambia (TBC)
Patent pools: what to learn from other fields of technology?
Ms. Hélène Jay, Director Business Development Europe, Via Licensing
An industry Perspective
Mr. Gregg Alton, Senior Vice President and General Counsel, Gilead
The GSK Patent Pool
Mr. Jon Pender, Director Government Affairs, Global Access, IP & HIV/AIDS Issues, GSK
Generic industry perspective on the HIV/ AIDS medicines patent pool
Mr. Greg Perry, Director General, European Generics medicines Association
Towards the patent pool
Ms. Katy Athersuch, Coordinator, UK Stop AIDS Campaign
Questions and Answers
Wrap up and Conclusions, Dr Jorge Bermudez, Executive Secretary, UNITAID
Interpretation in English-French and French-English will be available.
For information contact: Borolim@who.int